We are a research group dedicated to the computational study of cancer at the genomic level.
Our lab is integrated in the Institute for Research Biomedicine (IRB) in Barcelona.
Our work on how alterations of ubiquitin-mediated proteolysis affect in cancer published in Nature Cancer
We are very happy to have published one of the first articles of the Nature Cancer journal. We have systematically [...]
We are very happy to announce that our manuscript on the mutational footprints of cancer therapies has been published [...]
We are very excited to release a new version of IntOGen, our framework to identify cancer genes and pinpoint [...]